Since co-founding the company in 2006, Patrick has led the steady growth of the company toward becoming a leading choice for ophthalmology pharmaceutical and biotech companies. Prior to launching Trial Runners, Patrick was with Eyetech Pharmaceuticals as Associate Director of Medical Affairs, providing strategic and management oversight to the post-marketing clinical research program for Macugen®, the first anti-VEGF treatment for neovascular age-related macular degeneration (wet-AMD). Patrick initially joined Eyetech in 2001 to co-manage the Macugen® pivotal phase III clinical trial. Patrick has over 18 years of experience in the industry, including clinical management roles at Pfizer, Roche and Schering-Plough. Patrick received his Bachelors degree from the State University of New York at Stony Brook, and his Master of Public Health degree from the University of South Carolina, School of Public Health.